DE60131423D1 - Ratten-spezifische cathepsin, dipeptidyl peptidase i (dppi): kristallstruktur, hemmstoffe und deren anwendungen - Google Patents

Ratten-spezifische cathepsin, dipeptidyl peptidase i (dppi): kristallstruktur, hemmstoffe und deren anwendungen

Info

Publication number
DE60131423D1
DE60131423D1 DE60131423T DE60131423T DE60131423D1 DE 60131423 D1 DE60131423 D1 DE 60131423D1 DE 60131423 T DE60131423 T DE 60131423T DE 60131423 T DE60131423 T DE 60131423T DE 60131423 D1 DE60131423 D1 DE 60131423D1
Authority
DE
Germany
Prior art keywords
dppi
dipeptidyl peptidase
ingredients
applications
crystal structure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60131423T
Other languages
English (en)
Other versions
DE60131423T2 (de
Inventor
Johan Gotthardt Olsen
Anders Kadziola
Soeren Weis Dahl
Connie Lauritzen
Sine Larsen
John Pedersen
Dusan Turk
Marjetka Podobnik
Igor Stern
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Prozymex ApS
Original Assignee
Prozymex ApS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prozymex ApS filed Critical Prozymex ApS
Publication of DE60131423D1 publication Critical patent/DE60131423D1/de
Application granted granted Critical
Publication of DE60131423T2 publication Critical patent/DE60131423T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B15/00—ICT specially adapted for analysing two-dimensional or three-dimensional molecular structures, e.g. structural or functional relations or structure alignment
    • G16B15/20—Protein or domain folding
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2299/00—Coordinates from 3D structures of peptides, e.g. proteins or enzymes
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B15/00—ICT specially adapted for analysing two-dimensional or three-dimensional molecular structures, e.g. structural or functional relations or structure alignment

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Biotechnology (AREA)
  • Theoretical Computer Science (AREA)
  • Medical Informatics (AREA)
  • Evolutionary Biology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE60131423T 2000-09-08 2001-09-06 Ratten-spezifische cathepsin, dipeptidyl peptidase i (dppi): kristallstruktur, hemmstoffe und deren anwendungen Expired - Lifetime DE60131423T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DK200001343 2000-09-08
DKPA200001343 2000-09-08
US24758400P 2000-11-09 2000-11-09
US247584P 2000-11-09
PCT/DK2001/000580 WO2002020804A1 (en) 2000-09-08 2001-09-06 Rat cathepsin, dipeptidyl peptidase i (dppi): crystal structure, inhibitors and its uses

Publications (2)

Publication Number Publication Date
DE60131423D1 true DE60131423D1 (de) 2007-12-27
DE60131423T2 DE60131423T2 (de) 2009-03-19

Family

ID=26068872

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60131423T Expired - Lifetime DE60131423T2 (de) 2000-09-08 2001-09-06 Ratten-spezifische cathepsin, dipeptidyl peptidase i (dppi): kristallstruktur, hemmstoffe und deren anwendungen

Country Status (7)

Country Link
EP (1) EP1317555B1 (de)
AT (1) ATE378411T1 (de)
AU (1) AU3815102A (de)
CA (1) CA2422057C (de)
DE (1) DE60131423T2 (de)
DK (1) DK1317555T3 (de)
WO (1) WO2002020804A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE399763T1 (de) * 2003-05-30 2008-07-15 Prozymex As Proteasehemmer
EP1745292A2 (de) * 2004-04-28 2007-01-24 Bayer HealthCare AG Diagnositka und therapeutika für mit dipeptidyl-peptidase 1 (dpp1) assoziierten krankheiten
PL1942898T5 (pl) 2005-09-14 2014-10-31 Takeda Pharmaceuticals Co Inhibitory peptydazy dipeptydylowej do leczenia cukrzycy
CN102675221A (zh) 2005-09-16 2012-09-19 武田药品工业株式会社 用于制备嘧啶二酮衍生物的方法中的中间体
WO2007112347A1 (en) 2006-03-28 2007-10-04 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
TW200838536A (en) 2006-11-29 2008-10-01 Takeda Pharmaceutical Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor
NO2699580T3 (de) 2014-01-24 2018-02-24
KR20210032431A (ko) 2018-07-17 2021-03-24 인스메드 인코포레이티드 루푸스 신염을 치료하기 위한 특정 (2s)-n-[(1s)-1-시아노-2-페닐에틸]-1,4-옥사제판-2-카복스아미드

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5486623A (en) * 1993-12-08 1996-01-23 Prototek, Inc. Cysteine protease inhibitors containing heterocyclic leaving groups
US5637462A (en) * 1995-04-19 1997-06-10 Incyte Pharmaceuticals, Inc. Cathepsin C homolog
WO1997015588A1 (en) * 1995-10-26 1997-05-01 St. Jude Children's Research Hospital Protective protein/cathepsin a and precursor: crystallization, x-ray diffraction, three-dimensional structure determination and rational drug design
GB9522558D0 (en) * 1995-11-03 1996-01-03 Smithkline Beecham Plc Novel product and process
GB9606062D0 (en) * 1996-03-22 1996-05-22 Zeneca Ltd Promoters
GB9807293D0 (en) * 1998-04-03 1998-06-03 Univ Glasgow Leishmania cysteine proteinases
AU6495700A (en) * 1999-07-27 2001-02-13 Wake Forest University Methods and compositions for diagnosing palmoplantar keratodermas and dysplasiasand other periodontal diseases

Also Published As

Publication number Publication date
CA2422057C (en) 2012-11-27
WO2002020804B1 (en) 2002-07-25
EP1317555B1 (de) 2007-11-14
ATE378411T1 (de) 2007-11-15
DK1317555T3 (da) 2008-03-25
AU3815102A (en) 2002-03-22
DE60131423T2 (de) 2009-03-19
WO2002020804A8 (en) 2004-04-29
EP1317555A1 (de) 2003-06-11
WO2002020804A1 (en) 2002-03-14
CA2422057A1 (en) 2002-03-14

Similar Documents

Publication Publication Date Title
EA200501805A1 (ru) Фармацевтическая композиция, содержащая ингибитор фермента дипептидилпептидазы
ATE350374T1 (de) Phenylalaninderivate als hemmer der dipeptidyl peptidase zur behandlung oder prävention von diabetes
ATE451369T1 (de) Piperidinopyrimidindipeptidylpeptidaseinhibitor n zur behandlung von diabetes
EA200100992A1 (ru) Ингибиторы фермента impdh
ATE380175T1 (de) Pyrrolidine als dipeptidyl peptidase inhibitoren
BR9813658A (pt) Cristais de peptìdeo-1 semelhantes a glucagÈnio
EA200201271A1 (ru) Ингибиторы 11-бета-гидроксистероиддегидрогеназы типа 1
ATE226193T1 (de) Substituierte zyklische amine als metalloproteaseinhibitoren
ATE447574T1 (de) 3-amino-4-phenylbutansäurederivate als dipeptidylpeptidase-hemmer zur behandlung oder vorbeugung von diabetes
EA200400648A1 (ru) N, n'-замещенные производные 1,3-диамино-2-гидроксипропана
EA200300293A1 (ru) Противовоспалительные конденсированные пирролокарбазолы
DE69816280D1 (de) Inhibitoren des impdh-enzyms
ATE396993T1 (de) Tetrahydropyranyl-cyclopentyl- tetrahydropyridopyridin-modulatoren der chemokin- rezeptor-aktivität
CY1108146T1 (el) ΑΝΑΣΤΟΛΕΙΣ ΤΗΣ β-ΑΜΙΝΟ-ΕΤΕΡΟΚΥΚΛΙΚΗΣ-ΔΙΠΕΠΤΙΔΥΛΙΚΗΣ ΠΕΠΤΙΔΑΣΗΣ ΓΙΑ ΤΗΝ ΑΓΩΓΗ Ή ΠΡΟΛΗΨΗ ΤΟΥ ΔΙΑΒΗΤΗ
DE60126785D1 (de) Nicht-imidazol aryloxypiperidine als h3 rezeptor liganden
EA200100934A1 (ru) Применение ингибиторов cyp2d6 в комбинированных способах лечения
ATE527259T1 (de) Kondensierte aminopiperidine als dipeptidylpeptidase-iv-inhibitoren zur behandlung oder prävention von diabetes
DE60117814D1 (de) Nicht-imidazol aryloxyalkylamine als h3 rezeptor liganden
DK1206484T3 (da) Antipicornavirale forbindelser og sammensætninger, deres farmaceutiske anvendelser og materialer til deres syntese
BG104899A (en) Antipicornaviral compounds and compositions, their pharmaceutical use and materials for their synthesis
DE60140871D1 (de) Arylmethylamin-derivate zur verwendung als inhibitoren von tryptase
EA200200625A1 (ru) Антипикорнавирусные соединения и композиции, их фармацевтическое применение и вещества для их синтеза
ATE462703T1 (de) Bicyclononen-derivate als renin-inhibitoren
DE60131423D1 (de) Ratten-spezifische cathepsin, dipeptidyl peptidase i (dppi): kristallstruktur, hemmstoffe und deren anwendungen
EE200400031A (et) Biokeemiliste ühendite kompositsioon, selle kasutamine maatriks-metalloproteinaaside pärssimiseks ning seda sisaldav ravimpreparaat

Legal Events

Date Code Title Description
8364 No opposition during term of opposition